IP Law & Policy: What is Happening Inside the Beltway *

IP Law & Policy: What is Happening Inside the Beltway *

View Session Speakers

Intellectual property policy is seemingly always in the spotlight in Washington, D.C., with lawmakers, federal agencies, and the courts shaping decisions that could significantly impact innovation, competition, and IP protection across industries. This panel will provide an insider’s view of the latest developments inside the Beltway—from proposed legislation and USPTO initiatives to shifting judicial interpretations and regulatory trends. Hear from policy experts, former government officials, and industry advocates as they discuss what’s driving the current IP agenda, what’s gaining traction, ideas and initiatives losing momentum, and how stakeholders can engage effectively in the policymaking process. Whether you’re tracking patent reform, AI and IP issues, or trade-related concerns, this conversation will help you understand where IP policy is headed, what is happening at the USPTO, what is likely to happen in Congress, and what it all means for your organization.

Materials:

POPA Complaint Alleges Trump Executive Order is Retaliatory and Its Reasoning ‘Spurious’

Trump Order Bars USPTO Patents Employees from POPA Membership But Will Not Yet Affect Telework

C4IP Urges FTC to Proceed with Caution on Addressing Perceived Drug Pricing Problems

C4IP Slams ETHIC Act Targeting Patent Thickets as Destabilizing to Innovation Ecosystem

Trump Threatens Pharma to Deliver on Most Favored Nation Drug Pricing or Face Consequences

Bipartisan Bill Would Allow Courts to Compel ISP Blocking of Proven Foreign Piracy Sites

Purported Plan to Charge Patent Owners a Percentage of Patent Value is Fraught with Peril

Patent Eligibility Reform Returns to the Hill: PERA 2025 Explained

Despite Tweaks, PREVAIL 2025 Would Still Transform the PTAB

PREVAIL Act Narrowly Moves Forward Despite Concerns About Drug Pricing Impact

Survey:

https://www.surveymonkey.com/r/IP-Law-and-Policy